Prof. Christoph A. Nienaber new member of Medical Advisory Board of PHTS Telemedizin

SHL TeleMedicine Ltd.PHTS Telemedizin, the wholly owned German subsidiary of SHL Telemedicine Ltd. (SWX:SHLTN), has appointed Prof. Dr. med. Christoph A. Nienaber to its Medical Advisory Board. The renowned cardiologist strengthens PHTS Telemedizin with his cardiological competence and profound know-how in the implementation of telemedicine.

Prof. Nienaber holds the chair of cardiology at the University of Rostock and has been the head of the cardiological clinic for the last seven years. He has been a leading figure for several years in the structuring of telemedicine support programmes within the framework of integrated care and is recognized as one of the pioneers in the field. He is already working closely with PHTS Telemedizin. "Coronary heart diseases are a core field for the application of telemedicine and I am looking forward to using my experience to support the colleagues at PHTS Telemedizin with advice and action."

Personal HealthCare Telemedicine Services GmbH (PHTS), established in Düsseldorf in 2001, is a wholly owned subsidiary of SHL Telemedicine. PHTS Telemedizin (www.phts.de) combines innovative telemedicine solutions which have been proven in practice with well-founded medical-technical know-how. PHTS (www.phts.de) therefore holds a leading position throughout Germany in the field of cardiological telemedicine.

Related news article:

About SHL TeleMedicine
SHL TeleMedicine Ltd. is a leading provider and developer of advanced personal telemedicine solutions to individuals and to the healthcare community. As a provider of remote health services in cardiology and in other medical areas, SHL maintains business operations in the US, Europe and Israel. SHL is listed on the SWX Swiss Exchange, symbol SHLTN. For more information see www.shl-telemedicine.com.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...